ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD.

Zhejiang Garden Biopharmaceutical Co.,Ltd.

300401

CNE100001XX7

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-14 EDT			5-day change	1st Jan Change
11.9 ^CNY	-3.72%		-9.85%	+0.76%

05-09	Zhejiang Garden Biopharmaceutical Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 15 May 2024	CI
04-15	Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.

October 11, 2023 at 07:00 am

From September 14, 2023 to September 30, 2023, the company has repurchased 1,830,300 shares, representing 0.34% for CNY 21.05 million. With this, the company has completed the repurchase of 1,830,300 shares, representing 0.34% for CNY 21.05 million under the buyback announced on September 14, 2023.

Latest news about Zhejiang Garden Biopharmaceutical Co.,Ltd.

Zhejiang Garden Biopharmaceutical Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 15 May 2024	05-08	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-15	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.	03-07	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback announced on September 14, 2023, has completed with 9,307,200 shares, representing 1.7% for CNY 100 million.	03-05	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Announces Board Appointments	02-23	CI
Zhejiang Garden Biopharmaceutical's Unit Gets Nod for Eight New Products	02-05	MT
Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.	01-03	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-20	CI
Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.	23-10-11	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on September 7, 2023.	23-09-14	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.	23-08-22	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. authorizes a Buyback Plan.	23-08-21	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-07	CI
Zhejiang Garden Biopharma Registers Acid Reflux Drug	23-08-04	MT
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 24, 2023	23-05-18	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. has Changed its Name to Zhejiang Garden Biopharmaceutical Co., Ltd	23-04-28	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Approves Cash Dividend for the Year 2022	23-04-18	CI
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Proposes Final Cash Dividend for the Year 2022	23-03-27	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. announced a financing transaction	23-02-13	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-21	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-15	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Announces 2021 Final Cash Profit Distribution Plan on A Shares, Payable on 18 May 2022	22-05-12	CI
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Approves Final Cash Dividend for the Year 2021	22-04-20	CI

Chart Zhejiang Garden Biopharmaceutical Co.,Ltd.

Duration

Period

Chart Zhejiang Garden Biopharmaceutical Co.,Ltd.

More charts

Company Profile

Zhejiang Garden Biopharmaceutical Co Ltd, formerly Zhejiang Garden Bio-chemical High-tech Co Ltd, is a China-based company mainly engaged in the research, development, production and sales of vitamin D3 upstream and downstream products. The Company's vitamin products mainly include lanolin cholesterol, food and pharmaceutical grade vitamin D3, 25-hydroxyvitamin D3 and others. The Company also focuses on the research and development, production and sales of high-tech barrier preparations in the fields of cardiovascular, nervous system and other chronic diseases. The other products of the Company include Levofloxacin Tablets, Doxofylline Injection, Lipoic Acid Injection, Escitalopram Oxalate Tablets and others.

Sector

Pharmaceuticals

Calendar

2024-05-16 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD.	+0.76%	911M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.28%	44.4B
OTSUKA HOLDINGS CO., LTD.	+24.60%	23.03B
SANDOZ GROUP AG	+19.22%	15.14B
CIPLA LIMITED	+12.87%	13.12B
ZYDUS LIFESCIENCES LIMITED	+44.67%	11.85B
ONO PHARMACEUTICAL CO., LTD.	-8.33%	6.99B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.22%	5.52B

Generic Pharmaceuticals

Zhejiang Garden Biopharmaceutical Co.,Ltd.

Equities

300401

CNE100001XX7

Pharmaceuticals

Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.

Latest news about Zhejiang Garden Biopharmaceutical Co.,Ltd.

Chart Zhejiang Garden Biopharmaceutical Co.,Ltd.

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Generic Pharmaceuticals